Detection of Chlamydia pneumoniae by polymerase chain reaction-enzyme immunoassay in intestinal mucosal biopsies from patients with inflammatory bowel disease and controls - PubMed (original) (raw)

Comparative Study

Detection of Chlamydia pneumoniae by polymerase chain reaction-enzyme immunoassay in intestinal mucosal biopsies from patients with inflammatory bowel disease and controls

Wangxue Chen et al. J Gastroenterol Hepatol. 2002 Sep.

Abstract

Background and aim: It has been suggested that Chlamydia is an organism that may have the potential to cause inflammatory bowel disease (IBD) in susceptible individuals. Chlamydia pneumoniae has emerged as an important human pathogen in the last decade. The objective of the present study was to investigate the frequency of the presence of C. pneumoniae DNA in intestinal biopsies from patients with IBD and from non-IBD controls.

Methods: The DNA was extracted from 222 colonoscopic biopsies, which were obtained from 11 patients with Crohn's disease (CD), 18 patients with ulcerative colitis (UC) and from 37 non-IBD control patients. The presence of the C. pneumoniae omp1 gene and C. trachomatis 16S rRNA gene was determined using a rapid and sensitive polymerase chain reaction-enzyme immunoassay (PCR-EIA).

Results: The C. pneumoniae-specific DNA was detected in 32 (14.4%) of 222 endoscopic biopsies. Among them, C. pneumoniae DNA were found in nine of 42 (21.4%) biopsies from patients with CD, nine of 59 (15.3%) biopsies from patients with UC, and 14 out of 122 (11.4%) biopsies from non-IBD control patients, respectively. Moreover, the percentage of patients with at least one biopsy positive for C. pneumoniae was higher, although not statistically significant, in CD (36.4%) and UC patients (38.9%) compared to non-IBD controls (16.2%). In contrast, C. trachomatis DNA was detected in only two of 222 (0.9%) biopsy samples.

Conclusion: The C. pneumoniae DNA was detected in the intestine of both patients with IBD and in non-IBD control patients, probably reflecting the high prevalence of this organism in the environment. The moderate yield of positive biopsies in our IBD patients and the fact that the detection rate of C. pneumoniae DNA was similar in endoscopic biopsies from IBD patients and non-IBD controls does not support a direct role for this organism in the pathogenesis of IBD.

PubMed Disclaimer

Cited by

Simkania negevensis in Crohn's Disease.
Scaioli E, Biondi R, Liverani E, Sartini A, Troiano A, Fuccio L, Muratori R, Lombardi G, Onorini D, Dal Monte P, Donati M, Belluzzi A. Scaioli E, et al. Dig Dis Sci. 2019 Nov;64(11):3284-3290. doi: 10.1007/s10620-019-05632-4. Epub 2019 Apr 30. Dig Dis Sci. 2019. PMID: 31041636
Insights into the Two Most Common Cancers of Primitive Gut-Derived Structures and Their Microbial Connections.
Ray A, Moore TF, Naik DSL, Borsch DM. Ray A, et al. Medicina (Kaunas). 2024 Sep 18;60(9):1515. doi: 10.3390/medicina60091515. Medicina (Kaunas). 2024. PMID: 39336556 Free PMC article. Review.
Search for localized dysbiosis in Crohn's disease ulcerations by temporal temperature gradient gel electrophoresis of 16S rRNA.
Seksik P, Lepage P, de la Cochetière MF, Bourreille A, Sutren M, Galmiche JP, Doré J, Marteau P. Seksik P, et al. J Clin Microbiol. 2005 Sep;43(9):4654-8. doi: 10.1128/JCM.43.9.4654-4658.2005. J Clin Microbiol. 2005. PMID: 16145122 Free PMC article.
Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease.
Conte MP, Schippa S, Zamboni I, Penta M, Chiarini F, Seganti L, Osborn J, Falconieri P, Borrelli O, Cucchiara S. Conte MP, et al. Gut. 2006 Dec;55(12):1760-7. doi: 10.1136/gut.2005.078824. Epub 2006 Apr 28. Gut. 2006. PMID: 16648155 Free PMC article.

Detection of Chlamydia pneumoniae by polymerase chain reaction-enzyme immunoassay in intestinal mucosal biopsies from patients with inflammatory bowel disease and controls - PubMed (original) (raw)